Changes and problematic areas in interpretation of the AJCC Cancer Staging Manual, 6th Edition, for breast cancer

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 3, 2006, Pages 287-291

  Connolly, James L ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOOK; BREAST CANCER; CANCER STAGING; CANCER SURGERY; CLINICAL EXAMINATION; CLINICAL PRACTICE; CONFERENCE PAPER; DIAGNOSTIC IMAGING; LYMPH NODE METASTASIS; MEDICAL SOCIETY; PATHOLOGY; PREDICTION; PROGNOSIS; STANDARD;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASM STAGING; PATHOLOGY, SURGICAL; PRACTICE GUIDELINES; PROBLEM SOLVING; PROGNOSIS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 33644967431     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer staging manual. Cancer. 2003;98:2740-2741.
2. Greene FL, Page DL, Fleming ID, et al, eds, for the American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
3. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830-849.
4. Yeh E, Slanetz P, Kopans DB, et al. Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol. 2005;184:868-877.
5. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer, I: the value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
6. Ogston KN, Miller ID, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast. 2003;12:320-327.
7. Kuerer HM, Newman LA, Smith TL, et al. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol. 1999;17: 460-469.